Credit Suisse Starts Esperion Therapeutics (ESPR) at Outperform

July 22, 2013 6:57 AM EDT Send to a Friend
Get Alerts ESPR Hot Sheet
Price: $30.96 +4.45%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 35
Trade ESPR Now!
Join SI Premium – FREE
Credit Suisse initiates coverage on Esperion Therapeutics (NASDAQ: ESPR) with a Outperform. PT $23.00.

For an analyst ratings summary and ratings history on Esperion Therapeutics click here. For more ratings news on Esperion Therapeutics click here.

Shares of Esperion Therapeutics closed at $17.28 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Credit Suisse

Add Your Comment